Once the prosecution had proved the elements of possession and trafficking of the dangerous drugs Delta-9- Tetrahydrocannabinol, the amount or quantity of the same seized is irrelevant. The court is entitled to convict the 21 accused person under section 39B(1)(a) of the DDA for trafficking. [53] The learned trial Judge had referred to the evidence of SD 7 who had questioned the method used by the chemist, SP 6 in extracting the drugs from the liquid oil, was insufficient and was an outdated methodology. SD 7 testified that the chemist, SP 6 should have used an additional methodology, namely HPLC or High Performance Liquid Chromatography which uses solvents. However it was the findings of the learned trial Judge that SD 7 did not say in his testimony that the test which uses gas, namely GCMS, which was employed by SP 6, could not produce THC or Delta-9-Tetrahydrocannabinol. [54] It was also the findings of the learned trial Judge that when SD 7 was cross-examined, he said that he had never done any analysis on the drugs THC but had only attended courses on the same. SD 7 also said that he is not a qualified chemist certified by the Chemistry Department of Malaysia. His evidence appears purely theoretical in nature which was never put into practice, as compared to the evidence of SP 6 who is a qualified chemist certified by the Chemistry Department of Malaysia and had vast experience in the field of analysis of various types of drugs. Thus, SD 7 could not claim to have any expertise in analysis of drugs THC. Therefore, in the absence of the evidence of SD 7 as to expertise in THC, there is no expert evidence adduced by the defence to rebut the evidence of SP 6, the chemist, whose evidence the learned trial Judge had accepted as being credible. 22 [55] The learned trial Judge was thus justified in accepting the evidence of SP 6 as being credible as compared to the evidence of SD 7 that failed to challenge the evidence of SP 6. [56] The defence did not adduce any other evidence to challenge the evidence of SP 6 in this respect. Hence the evidence of SP 6 stands unrebutted. The learned trial Judge did not err in this respect. Ground 2: Whether the Dangerous Drugs in the 1st and the 2nd charges were medicinal cannabis and as such are not caught within the ambit of the DDA: [57] The defence contends that the learned trial Judge erred when he failed to appreciate that even if there were activities of manufacturing (which was denied) by the appellant, they were meant for public good as the appellant was processing it for sale of the same as medicinal marijuana or cannabis which activities were not caught within the mischief of the DDA. The medicinal marijuana is not dangerous drugs. [58] This contention by the defence was considered by the learned trial Judge at great length. The learned trial Judge had referred to certain excerpts of the testimony of the appellant where he agreed that the oil which he sold did not have any certification/verification by any body of doctors or medical bodies, or even the Health Ministry as to its medicinal properties or health benefits. [59] The expert witness called by the defence, SD 7 agreed that cannabis has never been verified/certified as having some health benefits 23 in our country and it has never been used as medicine in any hospitals in our country. [60] The learned trial Judge agreed with the submission by the learned DPP that in the absence of any acknowledgement or verification by the Ministry of Health or any medicinal practitioners of any medicinal or health benefits of cannabis, whatever claim by the defence that cannabis has some medicinal benefits only amounts to quackery or health fraud, which amounts to a promotion of fraudulent or ignorant medical practices. [61] The appellant had stated in his defence that he does not know that his act contravened any law of the country. However, such ignorance of the law is not a defence. The appellant knew that he was selling oils that contain cannabis. This has been considered by the learned trial Judge when he held in his judgment at RR Jilid 1 pages 41-42 when he said that: “[62] Pembelaan yang diketengahkan oleh OKT juga jelas bersifat penafian semata-mata terhadap ketiga-tiga pertuduhan, mengenai pertuduhan pertama, penjelasan OKT adalah walaupun dia tahu bahawa minyak tersebut mengandungi dadah Cannabis akan tetapi OKT berkata beliau mengisi ke dalam botol-botol kecil bertujuan untk perubatan bagi penyembuhan beberapa jenis penyakit. Pembelaan OKT ini tidak disokong oleh mana-mana keterangan daripada doktor atau disahkan oleh Kementerian Kesihatan Malaysia. Walaupun pembelaan ada memanggil SD 4, ibu OKT dan SD 6, pengguna minyak ganja tersebut akan tetapi kedua-dua keterangan mereka tidak disahkan oleh lapuran perubatan daripada mana-mana pegawai perubatan.” 24 [62] We do not find any flaw in such findings by the learned trial Judge as there is no supportive evidence from any medical bodies or from the Health Ministry to confirm the contention of the appellant that the drugs possesses medicinal properties which is beneficial to the public. The act of the appellant in manufacturing the drugs is subjected to the laws of the country, with particular reference to the DDA. There is no exemption nor license granted to the appellant to possess, manufacture, handle, process or for the sale of the drugs under the DDA or any laws for that matter. There is also no authorization provided under the DDA or any regulations thereunder which allows the appellant to possess the drugs. [63] Therefore the contention by the appellant that the manufacturing of the cannabis was for medicinal purposes for public good, are not caught within the mischief of the DDA, has no merits. There was no error by the learned trial Judge in making such findings which warrants our appellate intervention. [64] On the submission by the defence that there has been calls by the executive to review the charges against the appellant, at this stage, that is beyond our call. The appellant submits newspaper reports and articles evidencing these calls and suggestion by the executive. Our view is this: Once the charges are registered with the courts, save and except it being withdrawn by the Public Prosecutor, the court’s duty is to consider the evidence that was adduced by the prosecution before the courts and to decide according to law. It is the prerogative of the Public Prosecutor whether to charge a person under the relevant laws and the duty of the courts is to hear the matter and decide accordingly. 25 Ground 3: The failure by the learned trial Judge to make a finding whether the defence had rebutted or otherwise the presumption under section 37(da) of the DDA: [65] The learned trial Judge had made affirmative findings on possession for the 3rd charge (refer to RR Jilid 1, pages 22-24, paragraphs 23-27). As the weight of the drugs, cannabis had exceeded the minimum statutory requirement under section 37(da)(vi) of the DDA (i.e. 200 gram or more), the learned trial Judge had applied the presumption under section 37(da) of the DDA after making an affirmative findings of possession. Hence, the learned trial Judge did not err when he applied the said presumption. [66] The complaint by the defence is that, the learned trial Judge failed to appreciate the defence of the appellant. There is no merit in this contention as the learned trial Judge had clearly in his grounds considered the evidence given: